Wockhardt has surged 14% to Rs 959 on the National Stock Exchange (NSE) on back of heavy volumes after the media report suggests that US drug regulator has cleared the company’s Chikalthana plant. - Pharma Jobs- PJ

Pharma Jobs- PJ

A DESTINATION FOR PHARMA JOBS SEEKERS.___________PJ MOTTO:- SHARE MORE, YOU WILL GET MORE.

Breaking

Post Top Ad

Post Top Ad

Friday, 16 September 2016

Wockhardt has surged 14% to Rs 959 on the National Stock Exchange (NSE) on back of heavy volumes after the media report suggests that US drug regulator has cleared the company’s Chikalthana plant.

 has surged 14% to Rs 959 on the National Stock Exchange (NSE) on back of heavy volumes after the media report suggests that US drug regulator has cleared the company’s plant.

The exchange has sought clarification from on September 16, 2016, with reference to appeared in CNBC TV 18 dated September 16, 2016 stating " The US Food and Drugs Administration (USFDA) clearsplant of Wockhardt,” BSE said in a statement.


The reply is awaited.

In July 2016, the company’s three units namely L-1facility, H-14/2 Waluj facility and B-15/2 Waluj facility in Maharashtra have received Establishment Inspection Report (EIR) with observations.

On August 8, the had issued an import alert on Wockhardt’s Ankleshwar plant for alleged violation of good manufacturing practices. Since then, the stock underperformed the market by falling 17% as compared to 1% rise in the S&P BSE Sensex till Thursday.

At 02:11 pm, the stock was up 11% at Rs 929 on the NSE, against 0.28% gain in the benchmark index. The trading volumes on the counter jumped nearly seven-fold with a combined 7.92 million shares changed hands on the NSE and BSE so far.

No comments:

Post a Comment

Note: only a member of this blog may post a comment.

Post Top Ad